Products

Aima Diagnostics
Aima Diagnostics
Clinical Decision Support & Reference
Aima Diagnostics provides AI-powered personalized interpretation of blood test results for individuals, physicians, and clinics, analyzing biomarkers within individual contexts for early disease detection and informed decisions.

See all 1 product →

About Aima Diagnostics

Aima Diagnostics is a healthcare AI company focused on transforming diagnostics through advanced artificial intelligence and machine learning. The company develops a medical AI platform that specializes in the interpretation of laboratory data, longitudinal biomarker analysis, and clinical decision support. Their technology aims to enhance the accuracy and speed of blood test interpretation by analyzing correlations between numerous parameters and identifying subtle deviations that traditional methods might miss. This personalized approach considers individual factors like age, sex, lifestyle, and geographic region, comparing patient data with millions of anonymized records to provide comprehensive medical analyses.

For physicians, Aima Diagnostics offers a secure web portal for accessing AI-powered diagnostics, designed to integrate seamlessly into existing clinical workflows. The platform provides fast, reliable, and data-driven reports that support early disease detection, optimize patient care, and improve treatment outcomes. By automating the initial, time-consuming phase of data synthesis, Aima Diagnostics allows physicians to focus more on clinical reasoning and patient communication, thereby increasing the speed of information processing without sacrificing depth. The company operates under a strict scientific and ethical framework, utilizing de-identified, real-world medical data and fully complying with GDPR and international data protection standards.

Aima Diagnostics also offers advanced liquid biopsy solutions for Minimal Residual Disease (MRD) and Early Cancer Detection. Their AI-powered blood test can screen for multiple cancers with a small blood sample, providing a fast, scalable, and patient-friendly solution. For cancer patients, MRD detection informs therapeutic decisions by identifying remaining tumor DNA in the blood, guiding treatment and monitoring for recurrence. The company is also developing a program for early cancer detection in the general population, aiming to identify early signs of cancer and determine their tissue of origin.

Focus Areas

Neurodegenerative diseases Alzheimer's disease AI in diagnostics Medical imaging analysis Digital biomarkers

Business Intelligence

Key InvestorsACCIÓ, EIT Health, Ship2B, GENESIS Ventures, Ona Capital
PartnershipsHospital de la Santa Creu i Sant Pau, Hospital Clínic de Barcelona, Germans Trias i Pujol Research Institute (IGTP)
TechnologyCloud-native, AI-powered algorithms for analyzing clinical data (e.g., MRI scans, cognitive assessments)

What Physicians Need to Know

Specialization
Aima Diagnostics specializes in AI-powered analysis and interpretation of laboratory blood test data, aiming to enhance diagnostic accuracy and facilitate early disease detection.
Key Differentiators
Their key differentiators include personalized interpretation that considers individual factors like age, sex, lifestyle, genetics, and historical data, moving beyond population-based norms. They also emphasize continuous medical validation by clinical experts and collaboration with laboratory networks to refine their AI models.
Technology Stack
Aima Diagnostics utilizes advanced artificial intelligence and machine learning algorithms, trained on millions of anonymized medical datasets. They are also developing a blockchain recording mechanism for blood test interpretations to ensure immutability and transparency. For cancer diagnostics, they combine cfDNA methylation sequencing with ultra-sensitive analytics to detect minimal residual disease (MRD) and for early cancer detection.
Focus on Accuracy & Speed
The company aims to eliminate human error and subjectivity in medical data interpretation, providing fast, reliable, and data-driven reports. Their algorithms can process data up to 50 times faster than traditional laboratory testing and achieve predictive accuracy exceeding 95%.
Research-Driven Approach
Aima Diagnostics is a research-focused organization, with its product evolving through the analysis of large-scale real-world laboratory data, identification of clinical patterns, and validation with physician experts.
Physician Tip

For physicians, Aima Diagnostics acts as an AI-assisted clinical decision support tool, augmenting capabilities by providing instantaneous, structured interpretations of blood test results. This allows physicians to shift their focus from time-consuming data processing to clinical reasoning and patient communication, potentially reducing diagnostic errors and improving the speed of information processing. The personalized reports offer deeper, data-driven insights by considering individual patient factors and historical data, which can aid in early disease detection and optimizing patient care. Aima's system is built on international clinical guidelines, peer-reviewed research, and medical consensus, ensuring scientific rigor and evidence-based medicine. Furthermore, the platform offers seamless integration with existing Electronic Health Records (EHR) and Laboratory Information Management Systems (LIMS) via API, or through a secure web portal.

Aima Diagnostics offers easy API integration for seamless connection with existing Electronic Health Records (EHR) and Laboratory Information Management Systems (LIMS). They also provide a secure web portal for clinics to access AI-powered diagnostics without additional hardware. The company actively seeks partnerships with clinics, laboratories, universities, and research centers to collaborate on AI-driven diagnostics and integrate their solutions into medical workflows. They also partner with LIS providers like Dendi to optimize billing and reimbursement processes for laboratories.

Products by Aima Diagnostics

1 product in the directory

Aima Diagnostics
Aima Diagnostics
Clinical Decision Support & Reference
Aima Diagnostics provides AI-powered personalized interpretation of blood test results for individuals, physicians, and clinics, analyzing biomarkers within individual contexts for early disease detection and informed decisions.

Reviews & Opinions

No web reviews on file yet for Aima Diagnostics. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Aima Diagnostics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Aima Diagnostics →

View all on YouTube

Press & Coverage

Aima Diagnostics
Aima Diagnostics Introduces Optional Blockchain Recording for Blood Test Interpretations
Aima Diagnostics is developing a blockchain-based mechanism for recording interpretations of laboratory blood test results, offering immutability and transparent verification for patients in the UK and US. This optional feature stores cryptographic proofs and metadata on the Layer-2 Ethereum network Base, ensuring data control remains with the user while complying with GDPR and HIPAA.
2026-09
Aima Diagnostics
Aima Diagnostics Benchmark: A New Standard for Evaluating Medical AI
Aima Diagnostics is developing a proprietary benchmark to objectively assess the quality of AI models for blood test interpretation. This standardized evaluation framework will use a 'Golden Dataset' of reference clinical cases to test new model versions before release, ensuring reproducible and consistent quality assessment.
2026-07
Aima Diagnostics
AI Blood Diagnostics in Crisis Zones u2013 Aima Saves Lives
Aima Diagnostics is deploying an AI-powered rapid blood analysis platform in conflict and disaster-affected regions, including Ukraine, Syria, and Sudan, to provide timely diagnoses where traditional laboratory infrastructure is limited. This portable system delivers comprehensive hematology and basic biochemistry results from a finger-prick blood sample in minutes, without requiring traditional lab equipment.
2026-09
Aima Diagnostics
The Augmentation of Clinical Practice: How Aima Diagnostics is Redefining Blood Test Interpretations
Aima Diagnostics is redefining blood test interpretations by providing instantaneous, structured analysis, allowing physicians to focus on clinical reasoning and patient communication. The platform acts as a decision-support tool, built on clinically-validated datasets, to enhance diagnostic accuracy and patient safety in the face of increasing data volume and time constraints.
2026-09
Tracxn
AIMA - 2026 Funding Rounds & List of Investors - Tracxn
AIMA (Aima Diagnostics) has raised a total of $601K from one Seed round on December 22, 2022, with IndieBio as its institutional investor.
2026-06
U.S. Department of Justice
United States Files False Claims Act Complaint Alleging Genetic Testing Medicare Fraud
The United States has filed a False Claims Act complaint against AIMA Business and Medical Support, LLC (AIMA), alleging the submission of false claims to Medicare for medically unnecessary genetic laboratory tests. AIMA is accused of billing Medicare Part B approximately $15.1 million for genetic tests on behalf of Selecta Laboratory, knowing the tests were not medically necessary or ordered by a treating physician.
2025-06
Aima Diagnostics
Standards for AI-Based Blood Data Processing. Version 1.2 | July 2025
Aima Diagnostics has developed Version 1.2 of its 'Standards for AI-Based Blood Data Processing,' published in July 2025. These standards apply to all AI-supported systems for analyzing and interpreting blood test results, including CBC, metabolic panels, and lipid/liver panels, with a focus on data security and regulatory compliance like GDPR and HIPAA.
2025-07
British Journal of Haematology (via ResearchGate)
Promises and challenges of artificial intelligence in haematological diagnostics
This peer-reviewed article from July 2025 discusses the transformative potential of AI in hematological diagnostics, including automation, accuracy, and novel biomarker discovery. It also addresses challenges such as dataset bias, lack of interpretability, and the need for regulatory oversight and clinician AI literacy for safe and effective clinical integration.
2025-07

Frequently Asked Questions

Aima Diagnostics offers AI-powered platforms for interpreting blood test results, aiming to enhance diagnostic accuracy and speed. Their technology analyzes hundreds of thousands of indicators, detects hidden anomalies, and provides personalized interpretations based on factors like age, sex, lifestyle, and historical data. They also have a platform that powers CE-IVD-ready assays for Minimal Residual Disease (MRD) detection and early cancer detection through liquid biopsy, utilizing cfDNA methylation sequencing with AI.
Aima Diagnostics prioritizes data security and regulatory compliance by processing anonymized patient data in full adherence to GDPR and international data protection standards. They utilize end-to-end encryption for patient data during all processing stages and implement advanced authentication and secure storage methods. Their proposed standards for AI-based blood data processing also emphasize compliance with HIPAA and other national data protection regulations, with data stored in encrypted environments and immutable audit trails.
While specific pricing for their core diagnostic AI platform isn't readily available, a related entity, AIMA Labs (which focuses on AI sales workers), offers tiered pricing for its services: Basic, Pro, and Enterprise. The Enterprise plan for AIMA Labs includes custom compliance options like HIPAA, SOC 2, and GDPR, suggesting that tailored solutions with varying cost structures may be available for healthcare institutions with specific needs.
Aima Diagnostics aims to provide physicians with a reliable decision-support tool, emphasizing that their AI is not meant to replace specialists but to augment their expertise. They collaborate with medical professionals to fine-tune AI algorithms and ensure alignment with clinical needs. Their partnerships also focus on integrating AI-driven diagnostics to optimize medical workflows.
Aima Diagnostics actively seeks partnerships with medical professionals, clinics, universities, research institutions, and philanthropic organizations to collaborate on AI-driven diagnostics. They have announced a partnership with ArtMediuz, a large laboratory network in Eastern Europe, to advance AI-powered laboratory test interpretation. They also engage in scientific collaboration and research with practicing physicians and researchers to ensure medical relevance and continuous model refinement.
Aima Diagnostics is a research-driven medical AI platform committed to advancing the science of laboratory data interpretation and clinical decision support. They emphasize continuous evolution of their technology, integrating the latest advancements in machine learning and data analysis. Their mission is to create the most accurate AI-based diagnostic system and make life-saving diagnostics accessible globally, including in underserved communities.
Aima Diagnostics' research methodology includes population-specific and individualized modeling that incorporates age, sex, ethnicity, geography, medication use, chronic conditions, and lifestyle factors. Their proposed standards for AI systems also mandate bias assessment, requiring models to undergo stratified performance audits across sex and gender, age groups, racial/ethnic backgrounds, and relevant comorbidity clusters.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.